Biorez, IncAugust 4, 2023

FDA 483 - Biorez, Inc - August 04, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Biorez, Inc

Record Details

An FDA inspection of Biorez, Inc. in New Haven, CT, a medical device establishment, revealed a significant issue regarding the lack of adequately established procedures for ensuring purchased services conform to specified requirements. Specifically, the firm used an unvalidated protocol for the sterilization of its Biobrace implant, indicating a serious lapse in quality control for a critical process.

Company: Biorez, Inc
Inspection Date: August 4, 2023
Product Type: Device
Office: Division of Northeast Imports
Person: Jeffrey J. Thibodeau (Power Trader/Data Scientist)

Open in Dashboard

ID · b6ff8489-2d73-43a1-a712-68d2a3680869